In conclusion, we demonstrated that EVs from pan PPAR-iMSCs has anti-steatotic, anti-inflammatory, and tissue-repairing function, contributing to a marked improvement of NASH. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.